Ingrid van der Mei
Ingrid van der Mei
Menzies Institute for Medical Research, University of Tasmania
Verified email at - Homepage
Cited by
Cited by
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS
C Walton, R King, L Rechtman, W Kaye, E Leray, RA Marrie, N Robertson, ...
Multiple Sclerosis Journal 26 (14), 1816-1821, 2020
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
S Simpson, L Blizzard, P Otahal, I Van der Mei, B Taylor
Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1132-1141, 2011
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ...
Bmj 327 (7410), 316, 2003
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, F Pittas, H Tremlett, ...
Annals of neurology 68 (2), 193-203, 2010
Sun exposure and vitamin D are independent risk factors for CNS demyelination
RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ...
Neurology 76 (6), 540-548, 2011
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ...
Journal of neurology 254, 581-590, 2007
Ultraviolet radiation and autoimmune disease: insights from epidemiological research
AL Ponsonby, A McMichael, I Van Der Mei
Toxicology 181, 71-78, 2002
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
B Wood, IAF Van Der Mei, AL Ponsonby, F Pittas, S Quinn, T Dwyer, ...
Multiple Sclerosis Journal 19 (2), 217-224, 2013
Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation
IAF van der Mei, AL Ponsonby, L Blizzard, T Dwyer
Neuroepidemiology 20 (3), 168-174, 2001
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude
IAF van der Mei, AL Ponsonby, O Engelsen, JA Pasco, JJ McGrath, ...
Environmental health perspectives 115 (8), 1132-1139, 2007
UVR, vitamin D and three autoimmune diseases—multiple sclerosis, type 1 diabetes, rheumatoid arthritis
AL Ponsonby, RM Lucas, IAF van der Mei
Photochemistry and photobiology 81 (6), 1267-1275, 2005
Exposure to infant siblings during early life and risk of multiple sclerosis
AL Ponsonby, I van der Mei, T Dwyer, L Blizzard, B Taylor, A Kemp, ...
Jama 293 (4), 463-469, 2005
Monthly ambient sunlight, infections and relapse rates in multiple sclerosis
H Tremlett, IAF Van Der Mei, F Pittas, L Blizzard, G Paley, D Mesaros, ...
Neuroepidemiology 31 (4), 271-279, 2008
Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis
S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ...
Neurology 97 (19), e1870-e1885, 2021
Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1* 1501 on multiple sclerosis risk
KC Simon, IAF Van Der Mei, KL Munger, A Ponsonby, J Dickinson, ...
Neurology 74 (17), 1365-1371, 2010
Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis
F Pittas, AL Ponsonby, IAF van der Mei, BV Taylor, L Blizzard, P Groom, ...
Journal of neurology 256, 577-585, 2009
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study
AL Ponsonby, RM Lucas, IA Van Der Mei, K Dear, PC Valery, MP Pender, ...
Neurology 78 (12), 867-874, 2012
An adverse lipid profile is associated with disability and progression in disability, in people with MS
P Tettey, S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, T Dwyer, ...
Multiple Sclerosis Journal 20 (13), 1737-1744, 2014
Latitudinal variation in incidence and type of first central nervous system demyelinating events
BV Taylor, RM Lucas, K Dear, TJ Kilpatrick, MP Pender, IAF van der Mei, ...
Multiple Sclerosis Journal 16 (4), 398-405, 2010
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
N Stewart, S Simpson, I van der Mei, AL Ponsonby, L Blizzard, T Dwyer, ...
Neurology 79 (3), 254-260, 2012
The system can't perform the operation now. Try again later.
Articles 1–20